Press Releases

WASHINGTON, Feb. 4 – In a letter sent Monday to the CEO of Catalyst Pharmaceuticals, Sen. Bernie Sanders (I-Vt.) demanded the company explain its decision to set the price of Firdapse, a drug used to treat a rare neuromuscular disease called Lambert-Eaton myasthenic syndrome (LEMS), at $375,000 per year.   For two decades, patients have received the same drug – known

WASHINGTON, Jan. 31 – Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday on the amendment introduced by Majority Leader Mitch McConnell (R-Ky.) regarding the withdrawal of troops from Syria and Afghanistan: “American troops have been in Afghanistan for nearly 18 years, the longest war in American history. Our troops have been in Syria since 2015 under what I believe are

WASHINGTON, Jan. 31 – In an effort to combat rising wealth inequality, Sen. Bernie Sanders (I-Vt.) introduced legislation Thursday to establish a progressive estate tax on the fortunes of the top 0.2 percent of Americans and significantly increase rates on billionaires. Sanders’ legislation, the For the 99.8% Act, would raise $2.2 trillion from the nation’s 588 billionaires. In contrast, Senate Republican leadership proposed a bill this week that

WASHINGTON, Jan. 30 – Sens. Bernie Sanders (I-Vt.), Mike Lee (R-Utah) and Chris Murphy (D-Conn.) and Reps. Ro Khanna (D-Calif.), Mark Pocan (D-Wis.) and Pramila Jayapal (D-Wash.) renewed their efforts in the Senate and House Wednesday to end U.S. support for the Saudi-led war in Yemen pursuant to the War Powers Resolution.  As a result of the Saudi-led war, 14

WASHINGTON, Jan. 28 – Sen. Bernie Sanders (I-Vt.) issued the following statement after voting against S.1, which includes a provision to encourage state and local governments to pass laws suppressing Americans’ right to boycott Israel: “While I do not support the BDS movement, we must defend every American’s constitutional right to engage in political activity. It is clear to me